Galapagos



Ebitda Veränderung Datum
argenx SE 88.7M 103.13M 2024-09
AstraZeneca USD 5.26B 597M 2024-12
Biogen USD 754.8M 7.2M 2024-12
Genmab DKK 2.23B 85M 2024-09
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 2.08B 1.22B 2024-12
GRIFOLS EUR 536.1M 85.37M 2024-12
Hikma Pharmaceutical USD 453M 98M 2024-06
Incyte USD 320.2M 128.19M 2024-12
Merck EUR 1.42B 203M 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.25B 2.22B 2024-09
UCB EUR 652M 105M 2024-06
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Galapagos - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.